Stahl, S. M. (2014). "Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties." CNS Spectr 19(3): 207-212.

	A striking and unexpected pharmacologic synergy has been shown between antagonist actions at serotonergic 5HT2C receptors, and agonist actions at melatonergic receptors by agomelatine, a drug that has both of these properties.

